Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity Meriggioli MN; Sanders DBLancet Neurol 2009[May]; 8 (5): 475-90Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction in which patients experience fluctuating skeletal muscle weakness that often affects selected muscle groups preferentially. The target of the autoimmune attack in most cases is the skeletal muscle acetylcholine receptor (AChR), but in others, non-AChR components of the neuromuscular junction, such as the muscle-specific receptor tyrosine kinase, are targeted. The pathophysiological result is muscle endplate dysfunction and consequent fatigable muscle weakness. Clinical presentations vary substantially, both for anti-AChR positive and negative MG, and accurate diagnosis and selection of effective treatment depends on recognition of less typical as well as classic disease phenotypes. Accumulating evidence suggests that clinical MG subgroups might respond differently to treatment. In this Review, we provide current information about the epidemiology, immunopathogenesis, clinical presentations, diagnosis, and treatment of MG, including emerging therapeutic strategies.|*Myasthenia Gravis/diagnosis/epidemiology/physiopathology/therapy[MESH]|Adrenal Cortex Hormones/therapeutic use[MESH]|Age Factors[MESH]|Age of Onset[MESH]|Cholinesterase Inhibitors/therapeutic use[MESH]|Female[MESH]|Humans[MESH]|Immunosuppressive Agents/therapeutic use[MESH]|Immunotherapy[MESH]|Male[MESH]|Neuroimmunomodulation/physiology[MESH]|Neuromuscular Junction/physiopathology[MESH]|Receptor Protein-Tyrosine Kinases/immunology[MESH]|Receptors, Cholinergic/immunology[MESH]|Sex Factors[MESH]|Thymectomy[MESH] |